InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Angotti Vincent J., Chairman & CEO. Director active across 1 company, notably Acelrx Pharmaceuticals INC. Cumulatively, 5 reports have been recorded. Split: 1 buy · 0 sell. Total volume traded: €10k. Activity tracked since 6 February 2022. The latest transaction was filed on 7 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations5 total
46,400 shares@ US$0.222725.0% of flowCommon StockSEC:0001209191-22-035010:0
Ideal exit: 4 Mar 2023 (T+270)
23,051 shares@ US$0.406821.8% of flowCommon StockSEC:0001209191-22-016238:0
390,000 shares0Common StockSEC:0001209191-22-009343:0
27,318 shares@ US$0.431226.6% of flowCommon StockSEC:0001209191-22-007622:0
27,318 shares@ US$0.4312100.0% of flowCommon StockSEC:0001209191-22-007622
5 of 5 declarations
About Angotti Vincent J.
Vincent J. Angotti is the Chief Executive Officer of AcelRx Pharmaceuticals Inc. He is responsible for the strategic direction of the company and the management of its operations. With experience in the pharmaceutical sector, he is committed to promoting innovation and enhancing the therapeutic solutions offered by the company.
